VIRGINIA RETIREMENT SYSTEMS ET Al raised its stake in Docusign Inc. (NASDAQ:DOCU - Free Report) by 18.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 305,315 shares of the company's stock after acquiring an additional 47,000 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al owned about 0.15% of Docusign worth $20,884,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Central Pacific Bank Trust Division bought a new stake in Docusign in the fourth quarter valued at $25,000. Torren Management LLC bought a new stake in Docusign in the fourth quarter valued at $28,000. True Wealth Design LLC grew its position in Docusign by 105.2% in the fourth quarter. True Wealth Design LLC now owns 433 shares of the company's stock valued at $30,000 after acquiring an additional 222 shares during the period. Aventura Private Wealth LLC bought a new stake in Docusign in the fourth quarter valued at $30,000. Finally, CX Institutional grew its position in Docusign by 5,860.0% in the third quarter. CX Institutional now owns 596 shares of the company's stock valued at $43,000 after acquiring an additional 586 shares during the period. 77.64% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Docusign
In other news, CEO Allan C. Thygesen sold 26,250 shares of the company's stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $47.78, for a total transaction of $1,254,225.00. Following the transaction, the chief executive officer owned 152,237 shares of the company's stock, valued at $7,273,883.86. This represents a 14.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Robert Chatwani sold 16,696 shares of the company's stock in a transaction on Wednesday, March 18th. The shares were sold at an average price of $48.10, for a total value of $803,077.60. Following the transaction, the insider directly owned 72,458 shares in the company, valued at $3,485,229.80. This trade represents a 18.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 64,673 shares of company stock valued at $3,077,699 over the last ninety days. Company insiders own 1.01% of the company's stock.
Docusign Stock Down 0.2%
Shares of DOCU opened at $45.07 on Thursday. Docusign Inc. has a 12-month low of $40.16 and a 12-month high of $94.67. The firm has a market capitalization of $8.76 billion, a PE ratio of 30.45, a price-to-earnings-growth ratio of 1.72 and a beta of 0.88. The stock's fifty day simple moving average is $46.88 and its 200-day simple moving average is $56.46.
Docusign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.06. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The business had revenue of $836.86 million for the quarter, compared to analyst estimates of $828.23 million. During the same quarter in the prior year, the firm posted $0.86 earnings per share. The firm's revenue for the quarter was up 7.8% compared to the same quarter last year. Analysts anticipate that Docusign Inc. will post 1.76 EPS for the current year.
Docusign declared that its board has authorized a stock repurchase plan on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 21% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's management believes its stock is undervalued.
Analyst Ratings Changes
DOCU has been the topic of a number of analyst reports. HSBC set a $53.00 price target on Docusign in a research report on Friday, February 13th. Weiss Ratings cut Docusign from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Wednesday, April 15th. Jefferies Financial Group cut Docusign from a "buy" rating to a "hold" rating and lowered their price target for the company from $105.00 to $45.00 in a research report on Monday, February 23rd. Royal Bank Of Canada lowered their price target on Docusign from $70.00 to $55.00 and set a "sector perform" rating on the stock in a research report on Wednesday, March 18th. Finally, Robert W. Baird decreased their target price on Docusign from $75.00 to $55.00 and set a "neutral" rating on the stock in a report on Wednesday, March 18th. Three research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $61.40.
Check Out Our Latest Analysis on DOCU
Docusign Profile
(
Free Report)
DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Further Reading
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.